Browse > Article
http://dx.doi.org/10.15230/SCSK.2014.40.4.383

2D-QSAR Analyses on The Tyrosinase Inhibitory Activity of 2-[(2,6-Dioxocyclohexyl)methyl]-cyclohexane-1,3-dione Analogues  

Kim, Sang-Jin (Department of Cosmetic Science, Daejeon Health Sciences College)
Sung, Nack-Do (Department of Scientific Criminal Investigation, Chungnam National University)
Publication Information
Journal of the Society of Cosmetic Scientists of Korea / v.40, no.4, 2014 , pp. 383-390 More about this Journal
Abstract
The following conclusion was made from the 2D-QSAR model for the tyrosinase inhibitory activity according to the variation of the substituents R1 and R2 in analogues of compound 2-[(2,6-dioxocyclohexyl)methyl]cyclohexane- 1,3-dione (1-23). The best optimized 2D-QSAR model was $Obs.pI_{50}=-0.295({\pm}0.031)TDM$ $-0.120({\pm}0.014)DMZ+0.135({\pm}0.050)DMX.R_2+6.382({\pm}0.17)$, and the correlation $r^2=0.905$) of which was greater than its predictability ($q^2=0.843$). The magnitude of the effect of tyrosinase inhibitory activities was in order of TDM > $DMX.R_2{\geq}DMZ$, and it tended to increase as the hydrophobicity of substrate molecule (ClogP > 0) as well as the steric favor of substituent $R_1$ increased. The analysis of the model implies that inhibitory activity of substrate molecule will increase as $DMX.R_2$ (Dipole moment X component of $R_2$-substituent) increases, while TDM (Total Dipole Moment) and DMZ(Dipole Moment of Z-Component) decrease. As such, it is deemed feasible to conclude, that in order to increase the inhibitory effect, it would be rather desirable to replace the polar groups within the molecules with non-polar functional groups.
Keywords
2-[(2,6-dioxocyclohexyl)methyl]cyclohexane-1,3-diones; Tyrosinase inhibitory activity; 2D-QSAR model; Total dipole moment; ClogP;
Citations & Related Records
Times Cited By KSCI : 11  (Citation Analysis)
연도 인용수 순위
1 C. Yamagami, K. Araki, K. Ohnishi, K. Hanasato, H. Inaba, M. Aono, and A. Ohta, Measurement and prediction of hydrophobicity parameters for highly lipophilic compounds: application of the HPLC column-switching technique to measurement of log P of diarylpyrazines, J. Pharm. Sci., 88(12), 1299 (1999).   DOI
2 G. E. Kellogg and D. J. Abraham, Hydrophobicity: is LogP (o/w) more than the sum of its parts?, Eur. J. Med. Chem., 35(7-8), 651 (2000).   DOI
3 S. Parvez, M. Kang, H. S. Chung, C. Cho, M. C. Hong, M. K. Shin, and H. Bae, Survey and mechanism of skin depigmenting and lightening agents, Phytother. Res., 20(11), 921 (2006).   DOI   ScienceOn
4 K. Iozumi, G. E. Hoganson, R. Pennella, M. A. Everett, and B. B. Fuller, Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes, J. Invest. Dermatol., 100(6), 806 (1993).   DOI   ScienceOn
5 G. Prota, Progress in the chemistry of melanins and related metabolites, Med. Res. Rev., 8(4), 525 (1988).   DOI   ScienceOn
6 S. Akiu, Y. Suzuki, T. Asahara, Y. Fujinuma, and M. Fukuda, Inhibitory effect of arbutin on melanogenesis- biochemical study using cultured B16 melanoma cells, Jpn. J. Dermatol., 101(6), 609 (1991).
7 J. S. Chen, C. Wei, and M. R. Marshall, Inhibition mechanism of kojic acid on polyphenol oxidase, J. Agric. Food Chem., 39(11), 1897 (1991).   DOI
8 K. Maeda and M. Fukuda, Arbutin: mechanism of its depigmenting action in human melanocyte culture, J. Pharmacol. Exp. Ther., 276(2), 765 (1996).
9 T. S. Chang, An updated review of tyrosinase inhibitors, Int. J. Mol. Sci., 10(6), 2440 (2009).   DOI   ScienceOn
10 A. Palumbo, M. d'Ischia, G. Misuraca, and G. Prota, Mechanism of inhibition of melanogenesis by hydroquinone, Biochim. Biophys. Acta., 1073(1), 85 (1991).   DOI   ScienceOn
11 J. H. Seok, S. Y. Lee, E. J. Chae, and S. W. Choi, Skin whitening effects of Caragana sinica Rehder extract fermented by Saccharomyces cerevisiae KCTC 7913, J. Soc. Cosmet. Scientists Korea, 36(3), 207 (2010).   과학기술학회마을
12 S. Y. Lee, S. M. Lee, W. B. Heo, J. G. Kim, and Y. H. Kim, Effect of Nigella sativa oil on melanogenesis, J. Soc. Cosmet. Scientists Korea, 37(4), 319 (2011).   과학기술학회마을
13 Y. H. Chang, J. S. Ryu, S. H. Lee, S. G. Park, H. D. Bhattarai, J. H. Yim, and M. H. Jin, Inhibition of melanogenesis by ramalin from the antarctic lichen Ramalina terebrata, J. Soc. Cosmet. Scientists Korea, 38(3), 247 (2012).   과학기술학회마을   DOI
14 S. M. Lee, J. E. Kim, M. J. Oh, J. D. Lee, Y. J. Jeon, and B. Kim, Biological potential of enzymatic and polyphenol extracts from Ecklonia cava, J. Soc. Cosmet. Scientists Korea, 39(1), 19 (2013).   과학기술학회마을   DOI
15 J. Y. Lee, K. R. Im, T. K. Jung, and K. S. Yoon, The inhibitory effects of Alnus Japonica Steud. extract on melanogenesis, J. Soc. Cosmet. Scientists Korea, 39(2), 159 (2013).   과학기술학회마을   DOI
16 I. D. Kuntz, Structure-based strategies for drug design and discovery, Science, 257(5073), 1078 (1992).   DOI
17 S. S. Kwon, S. H. Jeon, J. M. Jeon, J. W. Cheon, and S. N. Park, Antioxidative effects of Inula britannica var. chinensis flower extracts according to the flowering period and species of Inula britannica var. chinensis, J. Soc. Cosmet. Scientists Korea, 39(3), 195 (2013).   과학기술학회마을   DOI
18 S. B. Han, S. S. Kwon, B. J. Kong, K. J. Kim, and S. N. Park, Antioxidative effect and tyrosinase inhibitory activity of the unripened fruit extract of Rubus coreanus Miquel, J. Soc. Cosmet. Scientists Korea, 39(4), 295 (2013).   과학기술학회마을   DOI
19 G. R. Marshall, Computer-aided drug design, Annu. Rev. Pharmacol. Toxicol., 27, 193 (1987).   DOI
20 P. J. Gane, and P. M. Dean, Recent advances in structure-based rational drug design, Curr. Opin. Struct. Biol., 10(4), 401 (2000).   DOI   ScienceOn
21 A. C. Anderson, The process of structure-based drug design, Chem. Biol., 10(9), 787 (2003).   DOI
22 R. V. Guido, G. Oliva, and A. D. Andricopulo, Virtual screening and its integration with modern drug design technologies, Curr. Med. Chem., 15(1), 37 (2008).   DOI
23 S. J Kim, S. G Kim, and N. D. Sung, CoMFA Analysis on inhibitory effect of $3{\beta}$-hydroxy-12- oleanen-28-oic acid analogues on PTP- 1B activity and prediction of active compounds, J. Soc. Cosmet. Scientists Korea, 34(2), 109 (2008).   과학기술학회마을
24 S. J. Kim, W. S. Choi, and N. D. Sung, Molecular docking and 3D-QSAR analysis on the tyrosinase inhibitory activity of tetraketone analogues, J. Kor. Soc. Cosm., 17(4), 759 (2010).
25 S. J. Kim, Y. H. Chung, S. G Kim, and N. D Sung, CoMSIA analysis on the inhibition activity of PTP-IB with $3{\beta}$-hydroxy-12-oleanen- 28-oic acid analogues, J. Korean Soc. Appl. Biol. Chem., 51(3), 171 (2008).   과학기술학회마을
26 S. J. Kim, N. D. Sung, and H. S Jung, Holographic quantitative structure-toxicity relationships on the skin sensitization of alkyl-3,4-dihydroxybenzoate and N-alkyl-3,4-dihydroxybenzamide derivatives, J. Soc. Cosmet. Scientists Korea, 31(1), 91 (2005).   과학기술학회마을
27 S. J Kim, Y. O. Kim, Y. K. Cho, W. S. Choi, and N. D. Sung, HQSAR analyses on the tyrosinase inhibitory activity of phenyl-2,2'- methylenebis(cyclohexane-1,3-dione) analogues, J. Soc. Cosmet. Scientists Korea, 36(3), 199 (2010).   과학기술학회마을
28 K. M. Khan, G. M. Maharvi, M. T. Khan, A. J. Shaikh, S. Perveen, S. Begum, and M. I. Choudhary, Tetraketones: A new class of tyrosinase inhibitors, Bioorg. Med. Chem., 14(2), 344 (2006).   DOI   ScienceOn
29 W. S. Choi, Master's Thesis Dissertation, Chungnam National University, Daejeon, Korea (2011).
30 A. Z. Dudek, T. Arodzb, and J. Galvezc, Computational methods in developing quantitative structure-activity relationships (QSAR): A review, Comb. Chem. High Throughput Screen, 9(3), 213 (2006).   DOI
31 T. Ghafourian, E. G. Samaras, J. D. Brooks, and J. E. Riviere, Validated models for predicting skin penetration from different vehicles, Eur. J. Pharm. Sci., 41(5), 612 (2010).   DOI